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Background: A high prevalence of tuberculosis (TB) in children presenting with severe pneumonia has previously
been reported in South Africa. However, little is known about TB among children with pneumonia in Uganda and
other resource limited countries. Moreover, TB is associated with high morbidity and mortality among such
children. We conducted this study to establish the burden of pulmonary TB in children admitted with severe
pneumonia in our setting.
Methods: A cross-sectional study was conducted at Mulago, a National Referral and teaching hospital in Uganda.
Hospitalised children 2 months to 12 years of age with severe pneumonia based on WHO case definition were
enrolledfrom February to June 2011. Children with a previous TB diagnosis or receiving anti-TB treatment were
excluded. Each child was screened for TB using Tuberculin skin test, Chest X-ray, induced sputum samples and
blood culture for mycobacterium. Sputum smears were examined using fluorescent microscopy, and cultured on
both Lowenstein Jensen media (LJ) and Mycobacterial Growth Indicator Tubes (MGIT).
Results: Of the 270 children with severe pneumonia who were recruited over a 5-month period in 2011, the
incidence ratio of pulmonary TB in children admitted with severe pneumonia was 18.9% (95% CI 14.6 – 23.9). The
proportion of culture confirmed PTB was 6.3% (95% CI 3.8 – 9.7). Age group under 1 year and 1 to 5 years (OR 2.8
(95% CI 1.7 – 7.4) and OR 2.4 (95% CI 1.05 – 5.9) respectively) were more likely to be associated with pulmonary TB
compared to those children over 5 years of age. A history of TB smear positive contact was associated with
pulmonary TB (OR 3.0 (95% CI 1.3–6.5).
Conclusions: We found a high burden of pulmonary TB in children admitted with severe pneumonia. These data
highlight the need for TB screening in children admitted with severe pneumonia so as to improve TB case finding
and child survival.Background
Tuberculosis (TB) is a global problem with about 9 mil-
lion incident cases in 2010 of whom children under 15 -
years accounted for about 10% [1]. Annually, an
estimated 400,000 deaths in children are associated with
TB. Some of these deaths may be due to delay in diagno-
sis since paediatric TB sometimes presents as an acute* Correspondence: ewobudeya@gmail.com
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distribution, and reproduction in any mediumpneumonia [2]. Globally, the pneumonia mortality
accounts for about 19% of deaths in children and 70% of
these deaths occur in sub-saharan Africa and East Asia
[3]. In Uganda, pneumonia contributes 21% of the under
five mortality ( U5M ) [4]. TB in children sometimes
presents as acute pneumonia [5] and TB is one of the
leading causes of morbidity and mortality across all age
groups throughout the world, especially in developing
countries [6,7]. In infants TB commonly manifest with
signs and symptoms of acute pneumonia [8] that may
lead to delay in diagnosis, prolonged hospital stay and
increased mortality. The diagnosis of TB in children still
remains a challenge and the proportion diagnosed duetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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delayed diagnosis of TB [9]. The need to increase TB de-
tection and reduce on the missed opportunities for early
diagnosis of TB in high risk populations that include
children has been highlighted by the WHO/TB STOP
partnership strategy for TB through intensified case
finding [10]. An understanding therefore, of the burden
of TB in children admitted with severe pneumonia will
not only heighten the index of suspicion but will also
call for the extension of the policy on intensified case
finding to pneumonia cases. An exploration of the clin-
ical characteristics associated with TB in children with
severe pneumonia would be useful. This study aimed to
establish the incidence ratio of pulmonary TB and de-
scribe the factors associated with pulmonary TB in chil-




This was a cross sectional analytical study.
Setting
The study was done at the Mulago National Referral
Hospital in Kampala, the capital city with a day popula-
tion of 2.5 million, HIV sero-prevalence of 8.5% among
adults, HIV sero-prevalence of 2.2% in children under
five and BCG vaccination coverage of 94.6%. This hos-
pital with a 1700-bed capacity and an annual turnover of
100,000 patients also serves as the primary health care
facility for the surrounding areas. The children were
recruited from the paediatric emergency unit between
February and June 2011. This paediatric emergency unit
has an annual turnover of 20,000 patients with pneumo-
nia admissions accounting for about 20% of the
admissions.
Participants and procedures
Children aged 2 months -12 years who fulfilled the
WHO case definition for severe or very severe pneumo-
nia and whose caretaker gave informed consent were eli-
gible to participate in the study. The children above
8 years of age provided assent. Children already on treat-
ment for TB were excluded. The enrolment was con-
secutive after at least a 24-hour admission period to
limit the misclassification of the cases that fulfil the
WHO criteria for severe pneumonia but are not pneu-
monia for example asthma and severe anaemia.
Severe pneumonia was defined as a presentation with
cough or difficulty in breathing, fast breathing and chest
in drawing. A very severe pneumonia case fulfilled the
case definition for severe pneumonia plus either cyan-
osis, convulsions or inability to feed [11]. The potentialparticipants were identified at the triage by the triage
nurse or the research assistant.
After obtaining informed consent, specific clinical his-
tory that included duration of cough, TB contact, weight
loss, BCG vaccination, previous pneumonia episodes
was obtained from the caregiver or parent. The children
were examined for BCG scar, peripheral lymphadenop-
athy and their weights and height obtained. The specific
investigations done included; Full blood count, blood
culture for mycobacterium, one sputum induction, tu-
berculin skin test (TST) placement by the Mantoux
method and chest radiography. The HIV serology results
were obtained from the Hospital Routine HIV counsel-
ling and testing (HCT) register. The caregivers or
parents were encouraged to have the children tested for
HIV within the hospital HCT program. The children
found to be HIV positive were linked to the HIV care
centre at the Mulago Hospital for further management.
The Chest radiography and placement of TST were done
on the day of enrolment. The TST was read within 48 –
72 hours by the same trained nurse who placed the skin
test. The one sputum induction was done early in the
morning within 24 hours of admission. The older chil-
dren provided at least 2 expectorated sputum samples.
The sputum samples were placed in a cool box with
ice packs and taken to the - Mycobacteriology Labora-
tory, Department of Microbiology, Makerere University
College of Health sciences for processing within 1 hour
of collection.
Laboratory investigations
Complete blood count was done using a coulter Act Diff 5
machine. Blood (2-5 ml) for Mycobacterial culture was
aseptically inoculated into BD BACTEC-MYCO/F-Lytic
media (Becton and Dickson, Franklin Lakes, NJ USA) for
up to six weeks at the Mycobacterialogy (BSL-3) labora-
tory. Cultures in which the machine flagged positive were
unloaded and a Ziehl Nelseen (ZN) smear for Acid Fast
Bacilli (AFB) was done. A portion was also inoculated
onto a Blood Agar Plate (BAP) to rule out contaminants.
Cultures that revealed AFB on ZN smear were subjected
to Capilia TB NeoTM (TAUN, Numazu, Japan) for identifi-
cation of Mycobacterium tuberculosis complex (MTBC).
However, cultures which were ZN negative and revealed
growth on BAP were considered contaminated.
Sputum samples were prepared for culture according
to laboratory standard operating procedures [12]. A vol-
ume 0.5 ml of the re-suspended deposit was inoculated
in a BACTEC BBL MGITTM 960 tube (Becton and
Dickson, Franklin Lakes, NJ USA). Additionally, two
drops were inoculated in LJ tubes (Becton and Dickson,
Franklin Lakes, NJ USA) and cultured. A smear for
fluorescent microscopy was also done according to
standard procedures [13].
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and 8 weeks on LJ media. For purity, any MGIT-positive
culture was sub-cultured at 37C on blood agar for 24 -
hours and a Ziehl Neelsen (ZN) smear done. Cultures
which were ZN-positive and pure (i.e. no growth on
blood agar) were subjected to Capilia TB NeoTM (TAUN,
Numazu, Japan) for identification of the MTB complex
[14]. Cultures with growth on blood agar but also ZN-
positive were sub-cultured again as described above; the
persistent ZN-negative cultures with growth on blood
agar were considered contaminated. All ZN-positive,
blood agar negative and Capilia TB NeoTM negative
samples were considered as having Mycobacteria Other
Than Tuberculosis (MOTT). Otherwise absence of col-
onies on LJ or fluorescence on MGIT was considered
negative. The data were entered into a computerized la-
boratory access database linked with patient records on
sample reporting form.
The main outcome measure was the diagnosis of pul-
monary TB. A case of Pulmonary TB is one that fulfilled
either the confirmed case or probable case definition
[15]. A confirmed case is one with culture confirmed
MTBC while a probably Pulmonary TB case is one with
at least one of the signs and symptoms suggestive of TB
AND Chest radiography consistent with intrathoracic
disease due to MTBC AND there is at least one of the
following; Documented exposure to MTBC infection,
Immunological evidence of MTBC infection. The chest
radiography reading for features of TB was done by 2 in-
dependent blinded radiologists with the third acting as a
tie-breaker.
The study was approved by the School of Medicine
Research and Ethics committee, Makerere University
College of Health Sciences. Written informed consent
was given by the parents/caretakers if they agreed to
their children participating in the study and assent was
obtained from older children. Children that were
diagnosed with Pulmonary TB were linked to the Na-
tional TB and Leprosy control program for care and
treatment.
Statistical issues
Using the Kish-Leslie formula, a minimum sample size
of 196 participants was sufficient to determine the bur-
den of Pulmonary TB among children admitted with se-
vere pneumonia while a minimum sample size of 257
with at least 43 TB cases was sufficient to explore
associated factors.
The data was captured using Epidata version 3.1 and
analyzed using SPSS (version 14.0). The proportion with
Pulmonary TB was determined with its 95% CI. The
continuous variables were summarized as means (SD) or
medians (IQR). Any associations with Pulmonary TB for
categorical variables were explored using the χ2 testwhereas normally distributed continuous variables were
tested using student’s t-test and skewed data using the
Mann-Whitney U test. Multivariate analysis using logis-
tic regression was carried out on variables with p- value
of less than 0.2 at bivariate to adjust for confounding. P
value <0.05 was considered significant.
Results
Participant descriptive statistics
A total of 285 children with severe or very severe pneu-
monia were enrolled and 270 were included in the ana-
lysis (Figure 1). The median age was 15 months (IQR 7–
36) with 85.5% of the study participants under 5 years of
age. The HIV seroprevalence was 15.2% and 0.7% were
HIV exposed but uninfected. Forty one children were
HIV positive. Fourteen had PTB and 27 had No TB.
Only 1 of the 14 TB cases was on ARVs while 6 without
TB were on ARVs. None was on isonaizide prophylaxis.
The majority, 93% (251/270), of caretakers reported
BCG immunisation with 75.3% (203/270) of the children
having a BCG scar. The WBC were similar; 13,680 in
PTB Vs 14, 299 in No PTB, p = 0.8, as well as the
Lymphocytes; 6567 in PTB Vs 7178 in No PTB, p=0.4.
Other baseline characteristics are shown in Table 1.
Incidence of pulmonary TB in children admitted with
severe pneumonia
Of the 270 children, 18.9% (95% CI 14.6 – 23.9) were
diagnosed with Pulmonary TB. The culture confirmed
cases were (17/270) 6.3% (95% CI 3.8 – 9.7) while
the probable cases were 12.6% (95% CI 9.0–17). Two
children (5 months and 8 years) had mycobacteremia
while one case (11 years) had both Pulmonary TB and
mycobacteremia. The remaining 14 had MTB confirmed
from sputum cultures. Forty seven percent (24/51) of the
children with PTB were under 2 years of age. Thirty four
percent of the HIV positive children had pulmonary TB
and 27.5% of the children with TB were co-infected with
HIV. The BCG scar was absent in 35.3% of the children
with TB compared to 26.9% of those without TB, the
difference was not statistically significant (p value = 0.2).
Abnormal CXRs were found in (45/51) 88% of PTB cases
Vs (136/219) 62% of None PTB cases OR 4.6 (1.8 – 11.2),
p < 0.001.
Factors associated with PTB in children admitted with
severe pneumonia
In children with severe pneumonia, the strongest clinical
associations with Pulmonary TB were; history of cough >
2 weeks, history of weight loss, history of contact with
PTB, age under 2 years, significant peripheral lymphaden-
opathy and HIV positive status (Table 2). On stratifying by
HIV status (data not shown), there was no association be-
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Figure 1 Study participant recruitment flow chart.
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HIV negative children, age under 2 years, history of con-
tact and peripheral lymphadenopathy remained associated
with Pulmonary TB at univariate analysis. Further com-
parison of some characteristics between the cultureTable 1 Baseline characteristics of children admitted with sev
Under 1 year
(n=101)
Cough > 2 weeks 34 (29.8%)
History of weight loss 49 (33.8%)
Peripheral lymphadenopathy 11 (22%)
History of TB Contact 11 (22.9%)
Previous pneumonia 26 (24.1%)
Moderate/severe malnutrition 22 (31.4%)
HIV positive 12 (29.3%)confirmed and culture negative PTB cases revealed no dif-
ference (Table 3).
At multivariate analysis, the factors that remained inde-
pendently associated with pulmonary TB were age under
five years and history of smear positive TB contact (Table 4).ere pneumonia (N=270)
Age group
1 – 5 years Above 5 years
(n=130) (n=39)
57 (50%) 23 (20.2%)
66 (45.5%) 30 (20.2%)
28 (56%) 11 (22%)
31 (64.6) 6 (12.5%)
56 (51.9%) 26 (24.1%)
37 (52.9%) 11 (15.7%)
21 (51.2%) 8 (19.5%)
Table 2 Comparison of participant characteristics with and without PTB admitted with severe pneumonia (N=270)
Variable PTB No PTB OR (95% CI) p –value
n=51 (%) n=219 (%)
History of cough
>2 weeks (42.2%) 32 (62.7) 82 (37.4) 2.8 (1.4 - 5.2) 0.001
<2 weeks (57.8%) 19 (37.3) 137 (62.6)
History of weight loss
Present (18.5%) 17 (33.3) 33 (15.1) 2.8 (1.4 - 5.6) 0.002
Absent (81.5%) 34 (66.7) 186 (84.90)
Peripheral lymphadenopathy
Present (18.5%) 16 (31.4) 34 (15.5) 2.4 (1.2 - 4.9) 0.009
Absent (81.5%) 35 (68.6 ) 185 (84.5)
Malnutrition (WHZ)
Moderate/severe (26%) 18 (35.3) 52 (23.7) 1.7 (0.9 - 3.3) 0.23
None/mild (74%) 33(64.7) 167 (76.3)
Anaemia*
Mod/severe (69.6%) 42 (82.4) 146 (66.7) 2.3 (1.07 - 5.0) 0.028
None/mild (30.4%) 9 (17.6) 73 (33.3)
HIV serology
Positive (15.2%) 14 (27.5) 27 (12.3) 2.6 (1.2 - 5.6) 0.007
Negative (84.8%) 37 (72.5) 192 (87.7)
TB contact
Yes (17.8%) 19 (37.3) 29 (13.2) 3.89 (1.9 - 7.7) <0.001
No (82.2%) 32 (62.7) 190 (86.8)
BCG immunisation
Yes (93%) 43 (84.3) 208 (95) 0.28 (0.1 - 0.74) 0.007
No (7%) 8 (15.7) 11 (5.0)
Age group
Under 1 year 13 (25.5) 88 (40.2) 0.008
1 – 5 years 24 (47.1) 106 (48.4)
Above 5 years 14 (27.5) 25 (11.4)
Definitions: WHZ, < -2 Z score – severe/moderate malnutrition. Z scores obtained using EpiInfo 3.5.1 Nutrition program. Anaemia, mod/severe, < 7 gm/dl for age
group less than 5 years OR < 8 gm/dl for age group 5 – 14 years.
Nantongo et al. BMC Pediatrics 2013, 13:16 Page 5 of 8
http://www.biomedcentral.com/1471-2431/13/16Discussion
We have shown that the incidence of PTB in children
admitted with severe pneumonia is high with about one
in five case of severe pneumonia also having pulmonary
TB. This result is important since pneumonia is a major
contributor to hospital admissions in most resource
limited settings and concomitant TB has been associated
with poor outcomes in both adults and children [5,16].
To the best of our knowledge, this is the first study done
in Uganda to find the burden of pulmonary TB in chil-
dren admitted with severe pneumonia. High rates of pul-
monary TB have been reported elsewhere in children
failing on pneumonia treatment [5]. The TB rates are
greatly influenced by the sensitivity and specificity of the
signs and symptoms employed to select the participants.A study conducted in our setting using the probable
case definition as the entry point for further evaluation
of pulmonary TB found a prevalence of 30% among chil-
dren attending the emergency paediatric department
[17] compared to our finding of 19% in children admit-
ted with acute pneumonia. There are several studies
conducted in South Africa that have investigated PTB in
children with acute lower respiratory tract infections
[5,18,19]. Moore D et al reported a similar finding in a
pneumococcal conjugate vaccine probe study where
18.5% of the episodes of lower respiratory infections
investigated had pulmonary TB [18]. Our study
compares well with this vaccine probe study [18] that
was conducted in the era of anti-retroviral therapy
(ART) availability and similar study setting except that
Table 3 Comparison of some characteristics of confirmed and culture negative PTB cases admitted with severe
pneumonia (N=51)
Variable Confirmed PTB Culture negative PTB OR (95% CI) p –value
n=17 (%) n=34 (%)
History of cough
>2 weeks (63%) 12 (71) 20 (59) 1.6 (0.4 - 5.8) 0.41
<2 weeks (37%) 5 (29) 14 (41)
History of weight loss
Present (59%) 11 (65) 19 (56) 1.4 (0.4 - 4.8) 0.5
Absent (41%) 6 (35) 15 (44)
History of wheezing
Yes (12%) 3 (18) 3 (9) 2.2 (0.3 - 12.3) 0.3
No (88%) 14 (82) 31 (91)
Peripheral lymphadenopathy
Present (31%) 5 (29) 11 (32) 0.8 (0.2 - 3.0) 0.8
Absent (69%) 12 (71 ) 23 (68)
Malnutrition (WHZ)
Moderate/severe (35%) 7 (41) 11 (32) 1.4 (0.4 - 4.8) 0.5
None/mild (65%) 10(59) 23 (68)
Anaemia*
Mod/severe (82%) 14 (82) 28 (82) 1 (0.2 - 4.6) >0.999
None/mild (18%) 3 (18) 6 (18)
HIV serology
Positive (28%) 3 (18) 11 (32) 0.4 (0.1 - 1.8) 0.2
Negative (72%) 14 (82) 23 (68)
TB contact
Yes (37%) 6 (35) 13 (38) 0.8 (0.2 - 2.9) 0.8
No (63%) 11 (65) 21 (62)
Reduced activity
Yes (67%) 13(76.5) 21(62) 2.0 (0.5 – 7.5) 0.2
No (33%) 4(23.5) 13(38)
CXR
Abnormal (41%) 7 (41) 14 (41) 1 (0.3 – 3.2) >0.999
Normal (59%) 10 (59) 20 (14)
BCG immunisation
Yes (84%) 14 (82) 29 (85) 0.8 (0.1 - 3.8) 0.7
No (16%) 3 (18) 5 (15)
Age group
Under 1 year (25.5%) 6 (35) 7 (21) 0.4
1 – 5 years (47%) 6 (35) 18 (53)
Above 5 years (27.5%) 5 (29) 9 (26)
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portion of confirmed MTB cases of 6.3% in our study
was similar to that reported by Moore D et al [18] of
6.7% but differs from that of 15% by McNally et al [5].
This difference between McNally and our study may beexplained by the fact that they studied a population of
treatment failures where the likelihood of PTB is much
higher. An alternative explanation could be the much
higher background HIV sero-prevalence of 36.5% at the
time of their study when there was no ready access to
Table 4 Multivariate analysis of factors independently
associated with pulmonary tuberculosis in children
admitted with severe pneumonia
Variable OR (95% CI) p-value
Age group (months ) Above 5 years 1
Under 1 year 2.8 (1.1 - 7.4) 0.028
1- 5 years 2.4 (1.05 - 5.9) 0.038
Cough for 2 or more weeks 1.7 (0.8 - 3.4) 0.11
History of TB contact 3.0 (1.3 - 6.5 ) 0.005
Peripheral lymphadenopathy 1.7 (0.7 - 3.7) 0.17
Positive HIV serology 1.3 (0.8 - 2.0 ) 0.15
Mod/severe Anaemia 1.9 (0.8 - 4.4) 0.12
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of 8.5% with ready access to ART. Among the HIV posi-
tive children, the proportion of culture confirmed TB
was 7.3% which is similar to a prevalence of 8% found
by Madhi SA. et al from South Africa [19]. Our study
set out to determine the incidence of PTB defined as
probable or culture confirmed PTB rather than culture
confirmed PTB alone in children admitted with severe
pneumonia.
In our study, children with a history of a smear posi-
tive TB contact in the past one year were three times
more likely to have pulmonary TB. A community study
in south Africa found a five-fold increased TB burden in
children with recent household TB contact [20]. Similar
findings have consistently been reported in several other
studies [17,21,22]. Age below 5 years and history of TB
contact were independently associated with pulmonary
TB in children admitted with severe pneumonia. In our
study, Children under 1 year and those between 1 and 5 -
years were about two to three times more likely to have
pulmonary TB compared to those above five years. This
finding is a reflection of the epidemiological distribution
of TB between 0 and 14 years where more TB is
observed in under fives compared to the above five years
age group [20].
Our findings therefore underscore the need for
extending the intensified case finding approach to in-
clude children admitted with severe lower respiratory
infections. This strategy is likely to increase paediatric
TB case detection and reduce on the missed opportun-
ities for early diagnosis of TB in children. Control of TB
in children has been given little attention because most
children are sputum smear negative and previously only
sputum smear positivity has been used for the estimates
of the magnitude of TB [23]. Our study’s finding of a
large number of culture proven TB in children with se-
vere pneumonia aged under five years calls for greater
emphasis on routinely performing sputum inductions
and cultures in children.Reducing the burden of TB in children in our setting
will require changing sputum examination policies to have
all sputum samples from children undergo culture. There
is need to improve early and proper diagnosis, early treat-
ment, contact tracing, and correct reporting of paediatric
TB. This commitment will require allocation of additional
resources for TB control [24] with increased attention to
paediatric TB.
This study was conducted in the emergency paediatric
unit where the children with severe pneumonia would be
captured. The study setting is similar to most health facil-
ities in Uganda. We believe this study can be generalised
to the emergency paediatric units within Uganda.
This study is limited by the inherently low yield rates
using the available diagnostic techniques due to the
paucibacillary nature of TB in children. The TB culture
that was the gold standard for confirmed TB in this
study has a yield rate of 30-40% [25]. We used the clin-
ical criteria that included both the confirmed and prob-
able cases in attempting to address this limitation. We
excluded 34 cases either at analysis or screening due to
either failure to obtain samples or lost results. If half of
these results were positive for MTB, this may have a
modest influence on our results either upwards or
downwards. However, given the known low MTB culture
yield from childhood samples, we believe our results are
an acceptable reflection of the burden of PTB in severe
pneumonia cases in our setting.
Conclusions
The incidence of pulmonary TB in children admitted
with severe pneumonia in Mulago Hospital is high. The
children with severe pneumonia aged below five years
with a recent smear positive TB contact are more likely
to have pulmonary TB when admitted with severe pneu-
monia. Further prospective research is required to get a
better understanding of the predictors of pulmonary TB
focusing on children of five years and below with severe
pneumonia.
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